Track the Eupraxia Pharmaceuticals Inc. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the authority of SEDI. Market capitalisation: €612.9m. The latest transaction was filed on 19 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Pott, Amy. The full history is accessible without an account.
37
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Eupraxia Pharmaceuticals Inc. Strong Buy (bullish), based on 2 analysts. Average price target: CA$16.00.
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.